Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, octobre 23
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
ImmuCell Corp
ICCC
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$10.25
-0.19
-1.82%
Dern. MÀJ: Oct 20, 5:26 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
ImmuCell Financials
ImmuCell (ICCC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
ImmuCell Sees Q3 Sales $8.000M
ImmuCell (NASDAQ:ICCC) sees Q3 sales of $8.000 million.
Benzinga Newsdesk
PRO
ImmuCell Reports Q3 Preliminary Sales Of $8M, Up 46% YoY
ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity,
Benzinga Newsdesk
PRO
ImmuCell Q2 EPS $0.20 Up From $0.06 YoY, Sales $7.186M Up From $6.445M YoY
ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.20 per share. This is a 233.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $7.186 million in sales
Benzinga Newsdesk
PRO
ImmuCell Q2 Total Product Sales Rises 12%
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity,
Benzinga Newsdesk
PRO
ImmuCell Q1 EPS $0.21 Up From $0.16 YoY, Sales $10.357M Up From $8.067M YoY
ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.21 per share. This is a 31.25 percent increase over earnings of $0.16 per share from the same period last year. The company reported $10.357 million in sales this
Benzinga Newsdesk
Earnings Scheduled For May 14, 2026
Benzinga Insights
